The office of the Congressionally Directed Medical Research Programs (CDMRP) manages Congressional Special Interest Medical Research Programs (CSI) encompassing various diseases, conditions, military health, and other specified areas. Since fiscal year 1992, the CDMRP has managed over $19.7 billion in Congressional appropriations for peer-reviewed research aimed at advancing paradigm shifting research, solutions that will lead to cures or improvements in patient care, or breakthrough technologies and resources for clinical benefit. Through fiscal year 2023, approximately 21,479 awards have been made to advance health care solutions via extramural grants, contracts, and cooperative agreements.

FY26 Funded Research Programs

• Alcohol and Substance Use Disorders
• Alzheimer's
• Amyotrophic Lateral Sclerosis
• Arthritis
• Autism
• Bone Marrow Failure
• Breast Cancer
• Combat Readiness-Medical
• Duchenne Muscular Dystrophy
• Epilepsy
• Hearing Restoration
• Joint Warfighter Medical
• Kidney Cancer
• Lung Cancer
• Lupus
• Melanoma
• Military Burn
• Multiple Sclerosis
• Neurofibromatosis
• Orthopaedic
• Ovarian Cancer
• Pancreatic Cancer
• Parkinson's
• Peer Reviewed Cancer
• Peer Reviewed Medical
• Prostate Cancer
• Rare Cancers
• Reconstructive Transplant Research
• Spinal Cord Injury
• Tick-Borne Disease
• Toxic Exposures
• Traumatic Brain Injury and Psychological Health
• Tuberous Sclerosis Complex
• Vision

Previously Funded Research Programs

• Chronic Pain Management
• Glioblastoma
• Gulf War Illness
• Neurotoxin Exposure Treatment Parkinson's
• Orthotics and Prosthetics Outcomes
• Scleroderma

Other Defense Health Program Support

• Defense Medical Research and Development